
Specialties: [[Medicine]] 
Date: 2023-09-10
Time: 18:58 
Keywords: 

### Class 
- [[Antiplatelet agents]] 
- [[Prodrug]]

### Mechanism
- ADP receptor blocker, downregulates [[Glycoprotein 2b-3a]] expression and reduces [[Platelet Aggregation]]


### Indications
- 


### Contraindications
- 


### Protocol/Procedure
- 


### Cautions
- Not effective in individuals with genetic polymorphisms of [[CYP enzymes]] or drug-induced inhibition of CYP enzymes (e.g., [[cimetidine]], [[amiodarone]], [[omeprazole]], etc.)


### Complications
- 


### Management of Complications
- 


### Related
- 